Grazoprevir/elbasvir treatment for the relapse of HCV genotype 1b infection after ledipasvir/sofosbuvir: A case report

The treatment of chronic hepatitis C has radically changed due to the development of direct-acting antiviral agents (DAAs). Twelve-week treatment with ledipasvir and sofosbuvir (LDV/SOF), a combination of DAAs, is highly effective in patients with hepatitis C virus (HCV) genotype 1 infection. Howeve...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Exp Ther Med
Main Authors: Tadokoro, Tomoko, Morishita, Asahiro, Oura, Kyoko, Fujita, Koji, Mimura, Shima, Sakamoto, Teppei, Nomura, Takako, Tani, Joji, Yoneyama, Hirohito, Masaki, Tsutomu
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2018
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6090207/
https://ncbi.nlm.nih.gov/pubmed/30116355
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2018.6207
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados